Related Experiment Video
Updated: Jan 22, 2026
11:13
Porcine Model of Infrarenal Abdominal Aortic Aneurysm
Published on: November 21, 2019
9.8K
Molecular Pharmacological Approaches for Treating Abdominal Aortic Aneurysm
Takashi Miyake1, Tetsuo Miyake1, Tomohiro Kurashiki1
1Department of Clinical Gene Therapy, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.
Annals of Vascular Diseases
|July 6, 2019
Summary
Abdominal aortic aneurysm (AAA) is a serious condition in older adults. Nucleic acid drugs show promise for treating AAA by targeting key molecules like microRNA and transcription factors.
Area of Science:
- Vascular Biology and Medicine
- Molecular Therapeutics
- Genetics and Epigenetics
Background:
- Abdominal aortic aneurysm (AAA) is a life-threatening condition in the elderly with no effective clinical treatments to halt its progression.
- Early detection of small AAAs is possible through routine screening, but therapeutic options remain limited.
- Molecular biology research has identified microRNAs and transcription factors as crucial players in AAA development.
Purpose of the Study:
- To review recent advancements in molecular therapies for abdominal aortic aneurysm (AAA).
- To explore the potential of nucleic acid drugs as a novel therapeutic strategy for AAA.
- To highlight the role of targeting microRNAs and transcription factors in AAA treatment.
Main Methods:
- Focuses on the mechanism of nucleic acid drugs in targeting specific molecules (mRNA, microRNA, transcription factors).
- Discusses sequence-specific binding leading to transcriptional or posttranscriptional regulation.
- Examines the decoy strategy for inhibiting transcription factors and its effect on AAA formation.
Main Results:
- Nucleic acid drugs offer a potential novel therapeutic approach for AAA.
- Inhibition of transcription factors using decoy strategies can suppress experimental AAA formation.
- Targeting specific genes involved in AAA progression is achievable through these molecular interventions.
Conclusions:
- Nucleic acid drugs represent a promising frontier in AAA molecular therapy.
- Targeting key molecular players like transcription factors and microRNAs is crucial for developing effective AAA treatments.
- Further research into nucleic acid-based therapies could lead to new clinical options for patients with abdominal aortic aneurysm.
Related Concept Videos
01:30Aneurysm I: Introduction
381
An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
381
01:25Abdominal Aorta
2.2K
Once the aorta traverses the diaphragmatic plane at the aortic hiatus, it is known as the abdominal aorta. This anatomical structure is positioned leftward of the spinal column, encased within a cocoon of adipose tissue behind the peritoneal cavity. It terminates at the L4 vertebra, where it splits into the common iliac arteries. Prior to this bifurcation, the abdominal aorta gives rise to several vital branches.
The celiac trunk, a singular artery, divides into the left gastric artery, which...
The celiac trunk, a singular artery, divides into the left gastric artery, which...
2.2K
02:00Molecular Models
43.6K
Physical models representing molecular architectures of chemical compounds play essential roles in understanding chemistry. The use of molecular models makes it easier to visualize the structures and shapes of atoms and molecules.
43.6K
01:26Aneurysm III: Interprofessional Care
264
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
264
01:20Ultrasound I: Abdominal Ultrasonography
1.5K
Introduction:
Abdominal ultrasonography, commonly known as abdominal ultrasound, is a vital, non-invasive medical imaging technique widely used in healthcare.
Procedure:
This diagnostic tool allows the clinician to visually inspect internal structures within the abdomen, including vital organs such as the liver, gallbladder, pancreas, kidneys, and spleen.
The abdominal ultrasound process begins with applying a special gel to the patient's skin over the abdomen. This gel enhances the...
Abdominal ultrasonography, commonly known as abdominal ultrasound, is a vital, non-invasive medical imaging technique widely used in healthcare.
Procedure:
This diagnostic tool allows the clinician to visually inspect internal structures within the abdomen, including vital organs such as the liver, gallbladder, pancreas, kidneys, and spleen.
The abdominal ultrasound process begins with applying a special gel to the patient's skin over the abdomen. This gel enhances the...
1.5K
01:19Abdominal Regions and Quadrants
16.7K
To promote clear communication, for instance, about the location of a patient's abdominal pain or a suspicious mass, anatomists and clinicians typically use imaginary lines to categorize the abdominopelvic cavity into either four quadrants or nine regions to identify organs in the cavity.
The simpler quadrants approach, which is more commonly used in medicine, subdivides the cavity with one horizontal and one vertical line that intersects at the patient's umbilicus (navel). The four...
The simpler quadrants approach, which is more commonly used in medicine, subdivides the cavity with one horizontal and one vertical line that intersects at the patient's umbilicus (navel). The four...
16.7K